Mirae Asset Global ETFs Holdings’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$615K Sell
5,740
-1,631
-22% -$107K ﹤0.01% 1890
2026
Q1
$58.3K Buy
7,371
+391
+6% +$6.32K ﹤0.01% 2867
2025
Q4
$120K Sell
6,980
-5,881
-46% -$114K ﹤0.01% 2584
2025
Q3
$331K Buy
12,861
+12
+0.1% +$453 ﹤0.01% 2061
2025
Q2
$739K Buy
12,849
+4,281
+50% +$343K ﹤0.01% 1598
2025
Q1
$927K Buy
8,568
+288
+3% +$25.1K ﹤0.01% 1542
2024
Q4
$393K Buy
8,280
+205
+3% +$12.4K ﹤0.01% 2043
2024
Q3
$793K Buy
8,075
+6,792
+529% +$877K ﹤0.01% 1667
2024
Q2
$210K Buy
+1,283
New +$183K ﹤0.01% 2225

Other funds holding AGL

Mirae Asset Global ETFs Holdings's AGL Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Agilon Health (AGL) stake by 22% in Q2 2026, selling an estimated $107K and leaving 5,740 shares worth $615K. The position accounts for ﹤0.01% of the portfolio, ranked #1890.

Mirae Asset Global ETFs Holdings first reported a position in AGL in Q2 2024 and has held it in 9 quarters since. The position peaked at $927K in Q1 2025. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 5,740 shares of Agilon Health worth $615K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 1,631 Agilon Health shares in Q2 2026, an estimated $107K.
  • Agilon Health made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1890 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Agilon Health in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Agilon Health position peaked at $927K in Q1 2025.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.